Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Research, informed consent, and the limits of disclosure.

Wilkinson TM.

Bioethics. 2001 Aug;15(4):341-63.

PMID:
11721682
2.

IRBs and pharmaceutical company funding of research.

Jellinek MS, Levine RJ.

IRB. 1982 Oct;4(8):9-10. No abstract available.

PMID:
11651693
3.

Should informed consent include information on how research is funded?

Finkel MJ.

IRB. 1991 Sep-Oct;13(5):1-3. No abstract available.

PMID:
11651248
4.

Sponsorship, authorship, and accountability.

Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Højgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS.

N Engl J Med. 2001 Sep 13;345(11):825-6; discussion 826-7. No abstract available.

5.

Academic relationships with industry: a new model for biomedical research.

Moses H 3rd, Martin JB.

JAMA. 2001 Feb 21;285(7):933-5. No abstract available.

PMID:
11180737
6.

In whose best interest? Breaching the academic-industrial wall.

Martin JB, Kasper DL.

N Engl J Med. 2000 Nov 30;343(22):1646-9. No abstract available. Erratum in: N Engl J Med. 2001 Feb 15;344(7):536.

PMID:
11096177
7.

To protect those who serve.

Drazen JM, Koski G.

N Engl J Med. 2000 Nov 30;343(22):1643-5. No abstract available.

PMID:
11096176
8.

A national survey of policies on disclosure of conflicts of interest in biomedical research.

McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, Brody BA.

N Engl J Med. 2000 Nov 30;343(22):1621-6.

9.

Conflict-of-interest policies for investigators in clinical trials.

Lo B, Wolf LE, Berkeley A.

N Engl J Med. 2000 Nov 30;343(22):1616-20.

10.

Policies on faculty conflicts of interest at US universities.

Cho MK, Shohara R, Schissel A, Rennie D.

JAMA. 2000 Nov 1;284(17):2203-8.

PMID:
11056591
11.

Uneasy alliance--clinical investigators and the pharmaceutical industry.

Bodenheimer T.

N Engl J Med. 2000 May 18;342(20):1539-44. No abstract available.

PMID:
10816196
12.

Is academic medicine for sale?

Angell M.

N Engl J Med. 2000 May 18;342(20):1516-8. No abstract available.

PMID:
10816191
13.
14.

The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals.

Edwards SJ, Lilford RJ, Hewison J.

BMJ. 1998 Oct 31;317(7167):1209-12. Review. No abstract available.

15.

Financial interest and its disclosure in scientific publications.

Krimsky S, Rothenberg LS.

JAMA. 1998 Jul 15;280(3):225-6.

PMID:
9676662
16.

Community equipoise and the architecture of clinical research.

Karlawish JH, Lantos J.

Camb Q Healthc Ethics. 1997 Fall;6(4):385-96. Review.

PMID:
9292216
17.

Participation of life-science faculty in research relationships with industry.

Blumenthal D, Campbell EG, Causino N, Louis KS.

N Engl J Med. 1996 Dec 5;335(23):1734-9.

18.

Relationships between academic institutions and industry in the life sciences--an industry survey.

Blumenthal D, Causino N, Campbell E, Louis KS.

N Engl J Med. 1996 Feb 8;334(6):368-73.

19.

Conflict of interest. The new McCarthyism in science.

Rothman KJ.

JAMA. 1993 Jun 2;269(21):2782-4. No abstract available.

PMID:
8192721
20.

Institutional conflict of interest.

Emanuel EJ, Steiner D.

N Engl J Med. 1995 Jan 26;332(4):262-7. No abstract available.

PMID:
7808495

Supplemental Content

Support Center